medroxyprogesterone acetate has been researched along with Bone Diseases, Metabolic in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, S; Kanda, T; Kasama, S; Kumakura, H; Kurabayashi, M; Murakami, M; Sumino, H; Takahashi, T; Takayama, Y | 1 |
| Kaunitz, AM; Tolaymat, LL | 1 |
| Beksinska, ME; Farley, TM; Kleinschmidt, I; Rees, HV; Smit, JA | 1 |
| El-Assal, MA; Farouk, OA; Fathallah, MM; Hussein, M; Mahran, DG; Romih, MS | 1 |
| Bachrach, L; Bone, H; Bruner, A; Burkman, R; Coupey, S; Cromer, B; Gold, MA; Harel, Z; Hertweck, P; Johnson, CC; Nelson, A; Nelson, D; Stager, M; Wolter, K | 1 |
| Chisolm, D; Kelleher, KJ; Klima, J; O'Brien, SH; Reed, S; Schwarz, EB | 1 |
| Chen, F; Lin, S; Lu, J; Shen, Y; Yu, W; Zhang, L; Zhang, Y | 1 |
| Brooks-Gunn, J; Fox, RP; Hamilton, L; Hamilton, WG; Holderness, CC; Hyle, EP; Warren, MP | 1 |
| Evans, MC; Grey, AB; Reid, IR; Stapleton, JP; Tatnell, MA | 1 |
| Bachrach, LK; Cundy, T; Ott, SM | 1 |
| Buemi, M; Frisina, N; Gaudio, A; Lasco, A; Morabito, N; Wasniewska, M | 1 |
1 review(s) available for medroxyprogesterone acetate and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Use of hormonal contraception in adolescents: skeletal health issues.
Topics: Adolescent; Adolescent Development; Bone Density; Bone Development; Bone Diseases, Metabolic; Contraceptives, Oral, Combined; Female; Humans; Medroxyprogesterone Acetate; Young Adult | 2009 |
3 trial(s) available for medroxyprogesterone acetate and Bone Diseases, Metabolic
| Article | Year |
|---|---|
[Prevention of bone loss by estradiol valerate combined with medroxyprogesterone acetate among postmenopausal women with osteopenia].
Topics: Adult; Bone Density; Bone Diseases, Metabolic; Drug Therapy, Combination; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Progesterone Congeners | 2002 |
Persistent osteopenia in ballet dancers with amenorrhea and delayed menarche despite hormone therapy: a longitudinal study.
Topics: Adult; Aging; Amenorrhea; Bone Density; Bone Diseases, Metabolic; Dancing; Drug Administration Schedule; Estrogens, Conjugated (USP); Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Menarche; Progesterone Congeners | 2003 |
Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
Topics: Aged; Bone Density; Bone Diseases, Metabolic; Calcium; Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hyperparathyroidism; Medroxyprogesterone Acetate; Middle Aged; Progesterone Congeners | 1996 |
7 other study(ies) available for medroxyprogesterone acetate and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Effects of raloxifene and hormone replacement therapy on forearm skin elasticity in postmenopausal women.
Topics: Aged; Bone Density Conservation Agents; Bone Diseases, Metabolic; Case-Control Studies; Elasticity; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Skin | 2009 |
Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception.
Topics: Bone Diseases, Metabolic; Case-Control Studies; Contraceptives, Oral, Combined; Cross-Sectional Studies; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; Time; Young Adult | 2009 |
Bone mineral density in women of a low socioeconomic level using DMPA for contraception in rural Upper Egypt.
Topics: Adult; Bone Density; Bone Diseases, Metabolic; Calcaneus; Contraceptive Agents, Female; Cross-Sectional Studies; Delayed-Action Preparations; Egypt; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis; Socioeconomic Factors; Time Factors; Ultrasonography; Young Adult | 2010 |
Inadequate vitamin D status in adolescents with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate injectable contraceptive: a pilot study.
Topics: Adolescent; Bone Density; Bone Diseases, Metabolic; Contraceptive Agents, Female; Drug Implants; Female; Humans; Medroxyprogesterone Acetate; Parathyroid Hormone; Pilot Projects; Vitamin D; Vitamin D Deficiency | 2010 |
Hormonal contraception use and pregnancy in adolescents with sickle cell disease: analysis of Michigan Medicaid claims.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Bone Diseases, Metabolic; Contraception Behavior; Contraceptives, Oral, Hormonal; Episode of Care; Female; Hospitalization; Humans; Medicaid; Medroxyprogesterone Acetate; Michigan; Pregnancy; Pregnancy in Adolescence; Prevalence; United States; Venous Thromboembolism; Young Adult | 2011 |
Depot medroxyprogesterone acetate in teens: A risk for bone health?
Topics: Adolescent; Age Factors; Bone Diseases, Metabolic; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone Acetate; Risk Factors | 2000 |
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major.
Topics: Adolescent; Adult; beta-Thalassemia; Bone Density; Bone Diseases, Metabolic; Case-Control Studies; Cross-Sectional Studies; Emergencies; Estradiol; Female; Guideline Adherence; Hormone Replacement Therapy; Hospitalization; Humans; Male; Medroxyprogesterone Acetate; Normal Distribution; Practice Guidelines as Topic; Regression Analysis; Statistics, Nonparametric; Testosterone | 2001 |